This Ridiculously Cheap Warren Buffett Stock Could Make You Richer

Kraft Heinz has paused its planned 2026 breakup and is instead pursuing a $600 million R&D and marketing push to stabilize sales and market share. The article argues the stock may be "ridiculously cheap" after years of underperformance, but highlights execution risk and the possibility Berkshire Hathaway could eventually sell its 27.5% stake. The setup is framed as a long-term value turnaround rather than a near-term catalyst.

Analysis

The market is treating KHC like a broken merger, but the more important setup is a forced simplification of the story. Pausing the split removes a near-term overhang that would have introduced two subscale equity stories, duplicated overhead, and a likely dispute over who deserves the better multiple; in the interim, one ticker with a stable cash engine is easier for capital allocators to own than two uncertain new entities. The second-order winner is any competitor with cleaner brand architecture and better pricing power, because KHC’s R&D/marketing ramp is effectively a defense campaign for shelf space rather than an offensive growth push.

The real catalyst path is not a quarter-to-quarter sales beat; it is evidence that volume decline bottoms before the market re-prices the equity. If management can show even low-single-digit organic stabilization over the next 2-4 quarters, the stock can rerate from “liquidate me” to “sum-of-parts optionality,” especially if leverage remains controlled and buybacks resume as a capital-allocation lever. The main tail risk is that the marketing spend merely buys time while private-label and fresher categories keep taking share, in which case the pause becomes a delay tactic and not a turnaround.

BRK.B matters less as a fundamental holder and more as a sentiment anchor. A gradual or partial reduction would create a technical air pocket, but the opposite is also true: as long as Berkshire does not rush for the exit, the market has to price the possibility that the asset is being vetted rather than abandoned. That makes the asymmetry attractive for patient capital, but only if sized like a governance/turnaround special situation, not a staple core holding.

Key Decisions for Investors

• Long KHC as a 12-24 month special-situation value position; size modestly and use sub-$30 entry zones if available. Target 20-30% upside on a stabilization rerate, with downside limited by cash generation unless volumes deteriorate again.
• Pair trade: long KHC / short a basket of high-multiple branded food names over 6-12 months if you expect share-recapture and turnaround spend to support KHC relative performance. Best if consumer demand remains defensive and rate cuts revive duration-sensitive multiples.
• Avoid chasing BRK.B on this name as a proxy long; if Berkshire remains a non-seller, the stock’s impact is mostly sentiment. If filing flow indicates active distribution, use that as a short-term hedge against a KHC long rather than as an independent thesis.
• Sell downside protection on KHC only if implied vol remains elevated and you are comfortable owning the equity through a 6-9 month execution window. The risk/reward is attractive for investors willing to be paid while waiting, but only around clear technical support.